The Galien Foundation Announces 2023 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup"
-- Award Candidates and Winners to be Presented on October 26, 2023, at the Prix Galien USA Forum in New York City
NEW YORK, July 27, 2023 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the 2023 Prix Galien USA Award nominees for "Best Digital Health Solution," "Best Medical Technology," and "Incubators, Accelerators and Equity." In partnership with Business France, nominees have also been announced for "Best Startup." Winners will be announced during the Prix Galien USA Forum on October 26, 2023, at the Alexandria Center for Life Science in New York City. Nominees in the "Best Medical Technology" category will be previewed during the Prix Galien USA Forum and, later that evening, category winners will be announced during the Prix Galien USA Awards Ceremony at the American Museum of Natural History in New York City.
(PRNewsfoto/The Galien Foundation)
"The Prix Galien Awards Committee is delighted to celebrate this remarkable group of candidates and selecting this year's winners will be no easy feat," said Bernard Poussot, Director, Roche Holding, Former Chairman & CEO, Wyeth, Prix Galien Medical Technology, Startup, Digital Health and Incubators, Accelerators and Equity Committee Chairman. "This great list of nominees reflects the undeniable courage, dedication, and passion behind each researcher continually working to deliver answers to patients around the world. We applaud their efforts and look forward to celebrating our shared goal of improving the human condition".
In its second year as a Prix Galien Award category, "Incubators, Accelerators and Equity," acknowledges the role played by these institutions in guiding the next wave of innovators by offering a range of mentoring skills, including clinical trial design expertise, legal counsel, lab space, professional development, peer-to-peer support, free access to leading advisors, and economic support to advance life science innovation.
"I'm honored to be returning as an Awards juror as we commend the unwavering commitment of each winner and award nominee in their perseverance of the advancement of global science, healthcare, and wellness," said Alex Gorsky, Former CEO and Executive Chairman, Johnson & Johnson, member of the Prix Galien Startup, Digital Health and Incubators, Accelerators and Equity Committee. "The outstanding quality of the submissions is a testament to the promising future of the life sciences industries."
Best Digital Health Solution (Nominees)
Abbott - NeuroSphere™ Virtual Clinic
Behavidence
Biocorp
Butterfly Network, Inc
Canvas Dx by Cognoa
Curio
Empatica
Evolve Medical Systems
Flow.is
Hyperion
Intellewave device
Medable
Metalytics
Mymee
NoviGuide
One Drop
Patientory, Inc
Revibe Technologies
Science 37
TECHMEDO
Therapixel
uMotif
Viz.AI
XRHealth
Best Medical Technology (Nominees)
Alcon
AcrySof™ IQ Vivity™ Extended Vision Intraocular
Lens (IOL)
Bausch + Lomb
XIPERE®
Body Vision Medical
LungVision™
Boston Scientific
ELUVIA™ Drug-Eluting Vascular Stent System
Boston Scientific
SpaceOAR VUE™ Hydrogel
Boston Scientific | Baylis Medical
VersaCross Transseptal Platform
CVRx®
Barostim™
Edwards Lifesciences
Edwards SAPIEN 3 Transcatheter Pulmonary Valve
System with Alterra Adaptive Prestent
Edwards Lifesciences
Edwards SAPIEN 3 Ultra RESILIA Transcatheter Aortic
Heart Valve
ENDOLOGIX LLC
DETOUR System
Flosonics Medical Inc.
FloPatch (catalog #FP120)
GT Medical Technologies, Inc.
GammaTile®
Guardant Health
Guardant360 CDx
Impel Pharmaceuticals Inc.
Trudhesa®
Impulse Dynamics
Optimizer® Smart Mini System
Lantheus
PYLARIFY® injection and PYLARIFY AI™
LifeVac, LLC
LifeVac
Olympus America Inc.
BF-UC190F Endobronchial Ultrasound (EBUS)
Bronchoscope
Organon
The Jada® System
Outset Medical, Inc.
Tablo® Hemodialysis System
Polarean
XENOVIEW™ (xenon Xe 129 hyperpolarized)
QT Medical Inc.
PCA 500
Roche
Elecsys® beta-Amyloid (1-42) CSF II (Abeta42) and
Elecsys® Phospho-Tau (181P) CSF (p-Tau181) assays
Solo-Dex, Inc.
Solo-Dex Fascile
Standard Bariatrics, Inc.
Titan SGS®
Terumo Aortic
Thoraflex Hybrid™
UNICANCER
Papillon system
Valencia Technologies Corporation
eCoin® Tibial Neurostimulator
Incubators, Accelerators and Equity (Nominees)
AION Labs
Center for Integrated Global Biomedical Sciences by University at Buffalo
Cube Labs
EIT Health Venture Centre of Excellence (VCoE)
Johnson & Johnson Innovation – JLABS
MATTER Startup Incubation
Mayo Clinic and Arizona State University MedTech Accelerator
MedTech Accelerator by mHUB Chicago
NHS Innovation Accelerator
Novartis Biome
OROT CONNECTED HEALTH INCUBATOR BY CIUSSS WEST CENTRAL MONTREAL
Villgro Africa
Walgreens Clinical Trials
Best Startup (Nominees)
4Moving Biotech
Acorai
Affini-T Therapeutics
Allergenis
Alviss.ai
Ascidian Therapeutics
As We Know
BigHat Biosciences
Biomunex Pharmaceuticals
BiPER Therapeutics
Bloqcube(R) and BloqBridge
Brainwatch
Carcinotech
CardioSignal
Cellarity
Click Therapeutics
DarwinHealth
DeepLife
Delix Therapeutics
Design Therapeutics
Emendo Biotherapeutics
EyeControl
Flare Therapeutics
Gameto
Geneos Therapeutics
Generate Biomedicines
Gleamer
GLX Analytix
GrayMatters Health
H2o therapeutics
HealthRhythms
HelloBetter
Immunis, Inc.
Intelligent Threads
Juno Diagnostics
Jurata Thin Film, Inc.
Lattice Medical
LifeMine Therapeutics
LinKinVax
Mantis Health
Manus Neurodynamica
Medesis Pharma
Medinn Pharma
MedRhythms
MindMics
Moon Surgical
My Friend The Sea
Neopredix
Novadiscovery
Omniscient Neurotechnology
Op2Lysis
Orano Med
Pentavere
ProfoundBio
Promontory Therapeutics
Raydiant Oximetry
ReST THERAPEUTICS
Rondol Industrie
SeqOne Genomics
Sleep Apnea Biotech Innovation
Step Pharma
Tessera Therapeutics
Tilak Healthcare
Usense
Volta Medical
WhiteLab Genomics
"It is an honor to serve again on the Prix Galien USA's Awards Committee to advance the mission of The Galien Foundation," said Joel S. Marcus, J.D., CPA, Executive Chairman & Founder, Alexandria Real Estate Equities, Inc./Alexandria Venture Investments. "This year's winners will represent transformational innovations in life science that have the potential to profoundly impact human health. We celebrate their enduring commitment to improving the lives of patients around the world."
The 2023 Prix Galien USA Medical Technology, Digital Health, Incubators, Accelerators and Equity, and Startup Awards Committee is composed of nine renowned leaders from the biomedical industry and academia, responsible for evaluating nominees. The 2023 Prix Galien Sub-Committees and Advisory Boards conduct a pre-screening of all applications before submitting the shortlist of award candidates to the Awards Committee.
Prix Galien Medical Technology, Digital Health, Incubators, Accelerators and Equity, and Startup Awards Committee 2023
Bernard POUSSOT
Director, Roche Holding, Former Chairman & CEO, Wyeth
Chairman
Roch DOLIVEUX
Honorary CEO, UCB
Mikael DOLSTEN
Global R&D President, Pfizer
Alex GORSKY
Former CEO & Executive Chairman, Johnson & Johnson
Penny HEATON
Global Therapeutic Area Head, Vaccines, Janssen
Sheri McCOY
Board of Directors, AstraZeneca, Former CEO, Avon
François MAISONROUGE
Senior Managing Director, Evercore Partners
Joel S. MARCUS
Executive Chairman & Founder, Alexandria
Elias ZERHOUNI
Former Head of Global R&D, Sanofi
Prix Galien Medical Technology Sub-Committee 2023
Lisa EARNHARDT
Executive Vice President, Medical Devices, Abbott
Robert S. LANGER
David H. Koch Institute Professor, Massachusetts Institute of Technology
Cato T. LAURENCIN
M.D., Ph.D., University Professor, University of Connecticut
Steven LESTER
M.D., Chief Medical Officer, Mayo Clinic-ASU MedTech Accelerator
Michel PAIRET
Head of Innovation Unit– Board of Managing Directors, Boehringer Ingelheim
Prix Galien Incubators, Accelerators, and Equity Category Sub Committee 2023
Gil BASHE
Managing Partner, Chair Global Health and Purpose, FINN Partners
Ron COHEN
M.D., Founder, President & CEO, Acorda Therapeutics
Jamey EDWARDS
Former CEO, Emergent Medical Associates
Amir KALALI
M.D., Chairman & Chief Curator CNS Summit/Co-Chair Decentralized Trial Research Alliance
Michelle LONGMIRE
M.D., Co-Founder & CEO, Medable Inc.
Cheryl PEGUS
M.D., Executive Vice President of Health & Wellness, Walmart
James PRUTOW
J.D., MBA, Advisory Partner – Life Sciences, Molecular Diagnostics, Global Healthcare, PwC Consulting
Prix Galien Startup Advisory Board 2023
Gaye BOK
Ph.D., Partner, AI and Digital Innovation Fun, Mass General Brigham
Elaine Brennan
Executive Director, Global Strategic Partnerships, Northwell Health
Christine BRENNAN
Ph.D., Managing Director, Vertex Venture HC
Luba GREENWOOD
Managing Partner, Dana Farber Cancer Institute Venture Fund
Rodolphe KATRA
Ph.D.,Sr. Research Director & Technical Fellow, Medtronic
Michael LANGER
Founder and Managing Partner at T.Rx Capital
Jonathan MARCHADO
Managing Director, Samsung Next
Detlev MENNERICH
Corporate SVP, Global Head of Business Development &Licensing (BD&L), Boehringer Ingelheim
Amir NAIBERG
Ass. Vice Chancellor, Technology Development Group, UCLA
Leighanne OH
MS, Life Sciences Investor, Novo Holding
Denis PATRIC
Ph.D., Emerging Science & Innovation, Partnering Pfizer
Dennis PURCELL
Founder, Aisling Capital
Uciane SCARLETT
Ph.D., Partner, MPM Capital
Prix Galien Digital Health Advisory Board 2023
Junaid BAJWA
Chief Medical Scientist, Microsoft Research, Microsoft
Joseph MOSCOLA
Executive Vice President, Enterprises Services, Northwell Health
Sachin NANAVATI
Head, Industry, Healthcare, Google
Jay RAJDA
M.D., Clinical Leader, Healthcare, Amazon
MaryAnne RIZK
Ph.D., Managing Partner, Rizk Management Advisors, Adjunct Professor, Stevens Institute of Technology
Steven ROSENBERG
Chief Executive Officer, uMotif
Daniel VIAL
Former Advisor of Sanofi CEO, Healthcare Consultant
About the Galien Foundation
The Galien Foundation fosters, recognizes, and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatments and technologies that will impact the state of medical practice and save lives.
The Foundation oversees and directs activities in the US for the Prix Galien, an international awards program dedicated to progress through innovative medicines development, with chapters in 14 countries and Africa. The Prix Galien was created in 1970 by Roland Mehl in honor of Galien, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.
About Business France
Business France is the national agency supporting the international development of the French economy, responsible for fostering export growth by French businesses, as well as promoting and facilitating international investment in France. It promotes France's companies, business image and nationwide attractiveness as an investment location, and also runs the VIE international internship program. For further information, please visit: www.businessfrance.fr - @businessfrance
For more information, visit www.galienfoundation.org.
Follow the Foundation on social media:
https://www.facebook.com/GalienFoundation/
https://twitter.com/GalienFdn
https://www.linkedin.com/company/the-galien-foundation/
Media Contact:
Kara Bradley
Finn Partners
Kara.Bradley@finnpartners.com
646-213-7243
SOURCE The Galien Foundation